Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Sequence Analysis, DNA × Thoracic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 35 Surveys and Questionnaires 23 Surgical Procedures, Operative 19 Carboplatin 19 pembrolizumab 16 Nivolumab 16 Immunotherapy 16 Immune Checkpoint Inhibitors 16 Drug Therapy 16 osimertinib 15 Radiotherapy 15 atezolizumab 14 Cisplatin 13 Specimen Handling 12 Observation 12 Gene Expression Profiling 12 Bevacizumab 12 Afatinib 12 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 lorlatinib 10 Immunohistochemistry 10 Biopsy 10 Paclitaxel 9 Erlotinib Hydrochloride 9 durvalumab 8 alectinib 8 Crizotinib 8 Therapeutics 7 Polymerase Chain Reaction 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03658460 2021-08-04

LimBio

Aalborg University Hospital

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡